Manufacturers ought to exhibit that any new technology or system not only satisfies the existing expectations for sterility assurance and also provides tangible benefits regarding effectiveness, trustworthiness, or solution safety. As these new technologies emerge, the WHO emphasizes the significance of a radical danger assessment and valida